AKR.L Regulatory News (AKR)

For immediate release: 10 DEC 2012

Akers Biosciences, Inc.

(the "Company")

Notice of Annual General Meeting

Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that a notice of the Company's Annual General Meeting, to be held at 11h00 EST on 20 December 2012 at RiverWinds Community Center, 1000 RiverWinds Drive, Thorofare New Jersey 08086, USA, has been posted to shareholders. All shareholders are welcome to attend in person or issue a proxy to vote on the resolutions at the Meeting. The Notice of the Annual General Meeting will also be available to view shortly on the Company's website, www.akersbiosciences.com.

Enquiries:

Thomas A. Nicolette

President and CEO

Tel. +1 856 848 8698

Antony Legge or Emma Earl

Daniel Stewart & Company plc (Nomad and Broker)

Tel. +44 (0)20 7776 6550

About Akers Biosciences, Inc.

Akers Biosciences develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health status information, both rapidly and directly, to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere, in minutes, since time is always of essence. ABI is aligned with high volume medical product distributors to help facilitate the Company's growth into a major, worldwide competitor in the field of rapid diagnostics. Additional information on the Company and its products can be found at www.akersbiosciences.com